OrbiMed Asia Partners V, L.P. — Form D/A
OrbiMed Asia Partners V, L.P. of New York, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-11-28. The offering totals $1.1B, of which $651.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-11-28
- Form: D/A
- Accession: 0001920536-22-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $1.1B
- Amount sold: $651.9M
- Remaining: $448.1M
- Investors: 68
- Date of first sale: 2022-04-29
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-443753
Issuer
- Name: OrbiMed Asia Partners V, L.P.
- CIK: 0001920536
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: 601 Lexington Avenue, New York, NY, 10022
- Phone: 212-739-6400
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Sven H Borho | Director | New York, NY |
| Carl L Gordon | Director | Stamford, CT |
| W. Carter Neild | Director | NEW YORK, NY |
| Sunny Carter Sharma | Director | Mumbai, K7 |
| David G Wang | Director | Shanghai, F4 |
| N/A OrbiMed Advisors V Limited | Executive Officer | New York, NY |
| N/A OrbiMed Asia GP V, L.P. | Executive Officer | New York, NY |
Other filings by this issuer (1)
More